Choriocarcinoma is a highly malignant tumor that arises from chorionic epithelium. About 50% of cases develop after molar pregnancies or hydatidiform moles, while 30% occur after miscarriages and 20% after normal pregnancies. The primary site is usually anywhere in the uterus, though rarely it starts in the fallopian tubes or ovaries. It spreads rapidly through vascular erosion, commonly metastasizing to the lungs in 80% of cases, anterior vaginal wall in 30%, and brain and liver in 10% each. Symptoms include persistent ill health, irregular vaginal bleeding, and continued amenorrhea, as well as coughing, breathlessness, or headaches from metastatic sites.